Literature DB >> 15296991

The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy.

A Nanashima1, Y Sumida, S Morino, H Yamaguchi, K Tanaka, S Shibasaki, N Ide, T Sawai, T Yasutake, T Nakagoe, T Nagayasu.   

Abstract

AIMS: The new Japanese staging system for hepatocellular carcinoma (HCC), the Japan integrated staging (JIS) score, accounts for both Child-Pugh classification and Japan tumour node metastasis (TNM) staging. However, in HCC patients who undergo hepatectomy, liver function is relatively good and a better prognostic classification of hepatic function is necessary.
METHODS: The present study was designed to analyse the modified JIS score using liver damage grade by the Liver Cancer Study Group of Japan instead of the Child-Pugh classification (using the category indocyanine green retention rate at 15 min [ICG(R15)] instead of encephalopathy), and to compare the Japan TNM stage in 101 patients who underwent resection of HCC.
RESULTS: The liver damage grade showed significantly better discrimination of disease-free and overall survival than did the Child-Pugh classification. The modified JIS score system showed significant differences of disease-free and overall survivals in each score and this system was superior for discriminating survivals compared with the TNM staging.
CONCLUSIONS: The combined staging system of hepatic function, particularly ICG(R15), and tumour stage provides a better prediction of prognosis. The JIS score using the liver damage grade was a useful predictor of prognosis of HCC patients who underwent hepatic resection.

Entities:  

Mesh:

Year:  2004        PMID: 15296991     DOI: 10.1016/j.ejso.2004.05.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  17 in total

1.  Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Melanie B Thomas; Deborah Jaffe; Michael M Choti; Jacques Belghiti; Steven Curley; Yuman Fong; Gregory Gores; Robert Kerlan; Phillipe Merle; Bert O'Neil; Ronnie Poon; Lawrence Schwartz; Joel Tepper; Francis Yao; Daniel Haller; Margaret Mooney; Alan Venook
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

2.  Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma.

Authors:  Nobuyoshi Fukushima; Ryoko Kuromatsu; Jun Akiba; Eiji Ando; Akio Takata; Shuji Sumie; Masahito Nakano; Toru Nakamura; Akihiko Kawahara; Takuji Torimura; Osamu Nakashima; Koji Okuda; Hirohisa Yano; Masayoshi Kage; Masamichi Kojiro; Michio Sata
Journal:  Exp Ther Med       Date:  2010-07-21       Impact factor: 2.447

3.  Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.

Authors:  Jean-Nicolas Vauthey; Elijah Dixon; Eddie K Abdalla; W Scott Helton; Timothy M Pawlik; Bachir Taouli; Antoine Brouquet; Reid B Adams
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 4.  Treatment algorithms for managing hepatocellular carcinoma.

Authors:  Vivek A Saraswat; Gaurav Pandey; Sachin Shetty
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

5.  A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy.

Authors:  Yukio Tokumitsu; Kazuhiko Sakamoto; Yoshihiro Tokuhisa; Hiroto Matsui; Satoshi Matsukuma; Yoshinari Maeda; Koichiro Sakata; Hiroshi Wada; Hidetoshi Eguchi; Hiroyuki Ogihara; Yusuke Fujita; Yoshihiko Hamamoto; Norio Iizuka; Tomio Ueno; Hiroaki Nagano
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

Review 6.  Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.

Authors:  Kichang Han; Jin Hyoung Kim
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

7.  Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.

Authors:  Atsushi Nanashima; Yorihisa Sumida; Takafumi Abo; Hisakazu Shindou; Hidetoshi Fukuoka; Hiroaki Takeshita; Shigekazu Hidaka; Kenji Tanaka; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu; Katsuhisa Omagari; Mariko Mine
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

8.  Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A.

Authors:  Young-Joo Jin; Jin-Woo Lee; Yong-Jun Choi; Hyun Jung Chung; Young Soo Kim; Kun-Young Lee; Seung Ik Ahn; Woo Young Shin; Soon Gu Cho; Yong Sun Jeon
Journal:  J Gastrointest Surg       Date:  2014-01-14       Impact factor: 3.452

9.  Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.

Authors:  Kai-Zhong Luo; Toshiyuki Itamoto; Hironobu Amano; Akihiko Oshita; Yuichiro Ushitora; Yoshisato Tanimoto; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

10.  Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score.

Authors:  Atsushi Nanashima; Junichi Masuda; Satoshi Miuma; Yorihisa Sumida; Takashi Nonaka; Kenji Tanaka; Shigekazu Hidaka; Terumitsu Sawai; Takeshi Nagayasu
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.